William J. Lipinski

1.3k total citations
20 papers, 1.1k citations indexed

About

William J. Lipinski is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, William J. Lipinski has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 9 papers in Physiology. Recurrent topics in William J. Lipinski's work include Alzheimer's disease research and treatments (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Prion Diseases and Protein Misfolding (4 papers). William J. Lipinski is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Prion Diseases and Protein Misfolding (4 papers). William J. Lipinski collaborates with scholars based in United States and Australia. William J. Lipinski's co-authors include Michael J. Callahan, Lary C. Walker, Feng Bian, Robert A. Durham, Alex E. Roher, Roy D. Schwarz, Michael D. Kane, George A. Mashour, Amanda J. Walker and Dinesh Pal and has published in prestigious journals such as Journal of Neuroscience, The Journal of Comparative Neurology and Brain Research.

In The Last Decade

William J. Lipinski

20 papers receiving 1.1k citations

Peers

Countries citing papers authored by William J. Lipinski

Since Specialization

Citations

This map shows the geographic impact of William J. Lipinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William J. Lipinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William J. Lipinski more than expected).

Fields of papers citing papers by William J. Lipinski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William J. Lipinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William J. Lipinski. The network helps show where William J. Lipinski may publish in the future.

Co-authorship network of co-authors of William J. Lipinski

This figure shows the co-authorship network connecting the top 25 collaborators of William J. Lipinski. A scholar is included among the top collaborators of William J. Lipinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William J. Lipinski. William J. Lipinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Immunotherapy: MACROPHAGE-DRUG CONJUGATE AS A CELL-BASED THERAPY FOR GLIOBLASTOMA	Cytotherapy	Maciej Białasek, Min Sun et al.	2
2	Determination of Minimum Alveolar Concentration for Isoflurane and Sevoflurane in a Rodent Model of Human Metabolic Syndrome	Anesthesia & Analgesia	Dinesh Pal, William J. Lipinski et al.	16
3	State-specific Effects of Sevoflurane Anesthesia on Sleep Homeostasis	Anesthesiology	Dinesh Pal, William J. Lipinski et al.	51
4	Isoflurane Anesthesia Does Not Satisfy the Homeostatic Need for Rapid Eye Movement Sleep	Anesthesia & Analgesia	George A. Mashour, William J. Lipinski et al.	43
5	The synthesis and structure–activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors	Bioorganic & Medicinal Chemistry Letters	Bradley W. Caprathe, Michael J. Callahan et al.	38
6	Aging, gender and APOE isotype modulate metabolism of Alzheimer's Aβ peptides and F₂‐isoprostanes in the absence of detectable amyloid deposits	Journal of Neurochemistry	Jun Yao, Suzana Petanceska et al.	33
7	Exogenous induction of cerebral β-amyloidosis in βAPP-transgenic mice	Peptides	Lary C. Walker, Michael J. Callahan et al.	71
8	Modeling Alzheimer's disease and other proteopathies in vivo: Is seeding the key?	Amino Acids	Lary C. Walker, Feng Bian et al.	26
9	Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25‐transgenic mice	The Journal of Comparative Neurology	Feng Bian, Rathna Nath et al.	80
10	Augmented Senile Plaque Load in Aged Female β-Amyloid Precursor Protein-Transgenic Mice	American Journal Of Pathology	Michael J. Callahan, William J. Lipinski et al.	234
11	Evidence for Seeding of β-Amyloid by Intracerebral Infusion of Alzheimer Brain Extracts in β-Amyloid Precursor Protein-Transgenic Mice	Journal of Neuroscience	Michael D. Kane, William J. Lipinski et al.	313
12	Milameline (CI-979/RU35926): A Muscarinic Receptor Agonist with Cognition-Activating Properties: Biochemical and In Vivo Characterization	Journal of Pharmacology and Experimental Therapeutics	Roy D. Schwarz, Michael J. Callahan et al.	33
13	Activation of the classical complement pathway by NMDA injection into the striatum of the neonatal rat	Molecular Immunology	K. Spiegel, C Raby et al.	1
14	Cerebral lipid deposition in aged apolipoprotein-E-deficient mice.	PubMed	Lary C. Walker, Carolyn Parker et al.	31
15	Cloning, Tissue Expression and Regulation of Rat Interleukin 1β Converting Enzyme	Cytokine	Karen M. Keane, David A. Giegel et al.	31
16	Nerve growth factor facilitates conditioned taste aversion learning in normal rats	Brain Research	William J. Lipinski, Kenneth W. Rusiniak et al.	15
17	In vitro and in vivo evaluation of the subtype-selective muscarinic agonist PD 151832	Life Sciences	Juan C. Jaén, Stephen D. Barrett et al.	18
18	PD 142676 (CI 1002), a novel anticholinesterase and muscarinic antagonist	Molecular Neurobiology	Mark R. Emmerling, V. Gregor et al.	9
19	Chapter 54: Subtype selective muscarinic agonists: potential therapeutic agents for Alzheimer's disease	Progress in brain research	Robert E. Davis, C Raby et al.	19
20	Tolerance to morphine stimulus control: role of morphine maintenance dose	Psychopharmacology	Alice M. Young, Christine A. Sannerud et al.	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact